Massive safety check for Fast-Acting agitation inhaler
NCT ID NCT03513549
Summary
This study aims to monitor the safety of an already-approved inhaled medication called ADASUVE, which is used to quickly calm severe agitation in adults with schizophrenia or bipolar disorder. It will observe up to 10,000 patients in real-world hospital and emergency settings to track any side effects. The goal is to better understand the safety profile of this fast-acting treatment when used in everyday clinical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION,PSYCHOMOTOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaceutical Research Associates, Inc
Raleigh, North Carolina, 27612, United States
Conditions
Explore the condition pages connected to this study.